SS
NPCE icon

SBI Securities’s Neuropace NPCE Stock Holding History

SBI Securities’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Sell
70
-100
-59% -$1.61K ﹤0.01% 2769
2026
Q1 		$2.24K Buy
170
+150
+750% +$2.25K ﹤0.01% 2381
2025
Q4 		$309 Sell
20
-1
-5% -$13 ﹤0.01% 3057
2025
Q3 		$217 Sell
21
-169
-89% -$1.59K ﹤0.01% 3290
2025
Q2 		$2.12K Hold
190
– – ﹤0.01% 2358
2025
Q1 		$2.33K Sell
190
-1
-0.5% -$13 ﹤0.01% 2221
2024
Q4 		$2.14K Buy
+191
New +$1.66K ﹤0.01% 2286

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SBI Securities's NPCE Position: Q2 2026 in Review

SBI Securities reduced its Neuropace (NPCE) stake by 59% in Q2 2026, selling an estimated $1.61K and leaving 70 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

SBI Securities first reported a position in NPCE in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.33K in Q1 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • SBI Securities held 70 shares of Neuropace worth $1.11K as of Q2 2026.
  • SBI Securities sold 100 Neuropace shares in Q2 2026, an estimated $1.61K.
  • Neuropace made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2769 holding.
  • SBI Securities first reported a position in Neuropace in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Neuropace position peaked at $2.33K in Q1 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.